GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.

Otros idiomas Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. Hong Kong S.E.

Acciones

874 CNE100000387

Farmacéuticos

Diferido Hong Kong S.E. Otros sitios de cotización 09:08:25 16/01/2026			Variación 5 días	Varia. 1 de enero.
18,71 ^HKD	+0,16 %		-0,21 %	+5,59 %

26/12	La unidad farmacéutica Baiyunshan obtiene aprobación en China para la vacuna contra la rabia	MT
23/12	Baiyunshan Pharmaceutical limita las transacciones con partes relacionadas con Guangyao Group para 2026	MT

Otros idiomas

26/12	Baiyunshan Pharmaceutical Unit Gets China Approval for Rabies Vaccine
23/12	Baiyunshan Pharmaceutical Caps 2026 Related-Party Transactions With Guangyao Group
22/12	Guangzhou Baiyunshan Pharmaceutical reports participation in establishment of GP Guangkai fund, GP Liwan fund
17/12	Guangzhou Baiyunshan Pharmaceutical says unit to buy 100% stake in Zhejiang Pharmaceutical Industry
16/12	Baiyunshan Pharma Unit Cancels Drug Production License
01/12	Guangzhou Baiyunshan Pharmaceutical says GP Corp. would sell accounts receivable to administrator
28/11	Baiyunshan Pharma to Receive Up to 449 Million Yuan in Land Reserve Compensation
27/11	Guangzhou Baiyunshan pharmaceutical Guanghua enters in land reserve compensation agreement
20/11	Baiyunshan Pharmaceutical's Unit Gets Registration Certificate From Vietnam for Angong Niuhuang Pills
18/11	Baiyunshan Pharma Gets Regulatory Nod to Acquire Stake in Nanjing Pharma
29/10/25	Baiyunshan Pharma's Q3 Profit Climbs 30%, Revenue Rises 10%; Shares Up 2%
28/10/25	Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2025
28/10/25	Guangzhou Baiyunshan pharmaceutical Q3 net profit up 30.3% Y/Y
25/09/19	Guangzhou Baiyunshan Phrmcl Hldgs : RESIGNATION OF A SUPERVISOR AND ELECTION OF A NEW SUPERVISOR
24/09/19	Guangzhou Baiyunshan Phrmcl Hldgs : Reply Slip for Attending the Second Extraordinary General Meeting in 2019 of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
24/09/19	Guangzhou Baiyunshan Phrmcl Hldgs : Proxy Form for the Second Extraordinary General Meeting in 2019
24/09/19	Guangzhou Baiyunshan Phrmcl Hldgs : NOTICE OF THE SECOND EXTRAORDINARY GENERAL MEETING IN 2019
10/09/19	Guangzhou Baiyunshan Phrmcl Hldgs : PROPOSED DISPOSALS OF ACCOUNTS RECEIVABLES
10/09/19	Guangzhou Baiyunshan Phrmcl Hldgs : INSIDE INFORMATION PROPOSED SPIN-OFF AND OVERSEAS LISTING OF GUANGZHOU PHARMACEUTICAL CORPORATION ON THE STOCK EXCHANGE OF HONG KONG LIMITED
09/09/19	Résumé des principales informations économiques du lundi 9 septembre 2019
09/09/19	Partners Group investiert in chinesischen Detailhandel und Bubble-Tee
09/09/19	Partners Group investit dans deux groupes en Asie
20/12/13	Pfizer Inc. : CORRECTED-From street stalls to bourses, SE Asia's traditional medicine makers promise panacea

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Otros idiomas Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. Hong Kong S.E.

Acciones

874

CNE100000387

Farmacéuticos

Otros idiomas

Filtros